| PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika SVOBODOVÁ, Jan OPPELT, Kateřina AMRUZ ČERNÁ, Jitka NOVOTNÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Eva VOJÁČKOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER a Marek MRÁZ. CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo. In AACR Annual Meeting Chicago Illinois USA. 2018. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1448118,
author = {Pavlasová, Gabriela and Borský, Marek and Svobodová, Veronika and Oppelt, Jan and Amruz Černá, Kateřina and Novotná, Jitka and Musilová, Kateřina and Šeda, Václav and Vojáčková, Eva and Brychtová, Yvona and Doubek, Michael and Pospíšilová, Šárka and Mayer, Jiří and Mráz, Marek},
booktitle = {AACR Annual Meeting Chicago Illinois USA},
keywords = {CD20; BCR; CLL},
language = {eng},
title = {CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo},
year = {2018}
}
TY - CONF
ID - 1448118
AU - Pavlasová, Gabriela - Borský, Marek - Svobodová, Veronika - Oppelt, Jan - Amruz Černá, Kateřina - Novotná, Jitka - Musilová, Kateřina - Šeda, Václav - Vojáčková, Eva - Brychtová, Yvona - Doubek, Michael - Pospíšilová, Šárka - Mayer, Jiří - Mráz, Marek
PY - 2018
TI - CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo
KW - CD20
KW - BCR
KW - CLL
N2 - CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo, CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo.
ER -
PAVLASOVÁ, Gabriela, Marek BORSKÝ, Veronika SVOBODOVÁ, Jan OPPELT, Kateřina AMRUZ ČERNÁ, Jitka NOVOTNÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Eva VOJÁČKOVÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Šárka POSPÍŠILOVÁ, Jiří MAYER a Marek MRÁZ. CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo. In \textit{AACR Annual Meeting Chicago Illinois USA}. 2018.
|
